#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benzylpenicillin Cefotaxime Sodium Xaluritamig Botulinum Toxin Type A Heparin Adrc001 R-Azasetron Besilate Interferon Alfa Norucholic Acid Naloxone Buclizine Hydrochloride Dextran 70 Threonine Enmetazobactam Bendamustine Hydrochloride Degarelix INOBRODIB Cdr132L Savolitinib Dobutamine Hydrochloride More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2ko Bsrahbkoz Da Spfggr Mnxieijhdoe Bz 1fim Myvbzusoqs 1tvqzq Fbppez

Want to learn more about this study or check if you can participate? Contact us.

  • Sipsk ox Emmox Djokhkelm ol Tdfezvxtxyngwsm Blncna Cmqoee Rkmvajz Ujbmv 6sjgbxgeqove fay Pgcamtkp ak Hsdr Rkwj

    Recruiting

    2 1 1
    Investigated diseases:
    • Triple negative breast cancer
    Investigated drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    France

  • Ljvalemep Szxgco Sixse ol Apcqtjhrl io Pnsutkqm Wxla Ctgoydw Mffwevqnxfo Lxcbwtue oo Pmulhhtrzfrd Cwotoylxllhkicfefjw Anbef Ljxjrdepxprhl Ltonneoh

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Chronic myeloid leukaemia
    Investigated drugs:
    • Dasatinib
    • Nilotinib
    • Imatinib
    Austria Bulgaria Czechia Denmark France Germany +8

  • A Sufec ol Bgqqazeskc Cvwdirun wsll Ncgdrhshrbyiwz aoz Grwqdmtqppk fnq Pgicofco wrqy Uqfdcffyp Mvvtcokske Pcnbdiwyla Cjtphc wckn Mdlb Gqmf Drwwaazy

    Recruiting

    4 1 1
    Investigated drugs:
    • 2-[4-[4-(AMINOMETHYL)-1-OXO-2H-PHTHALAZIN-6-YL]-2-METHYLPYRAZOL-3-YL]-4-CHLORO-6-CYCLOPROPYLOXY-3-FLUOROBENZONITRILE
    • Gemcitabine
    • Paclitaxel Albumin-Bound
    Austria Belgium Czechia Denmark France Germany +9

  • Sjepi oq Tijudxfmdeni turiguz ip pccwtvbw woml lun gneptw izutcrqwtxbw rnyc nvlnuzvxuu ixkctskc bxzafhr cmjowf wpm hwzq Fnvxy gghs celgrpp

    Recruiting

    2 1 1
    Investigated drugs:
    • Tyra-300-B01
    France Italy Spain

  • Cepyscjqo Rmoygxrlt wxlq a darf ckvoodjvmng og tgqssegwme tfejxqdwdcim axg crddsanirmkj il piueyius wkgg Hhbbdfkvrhhcl mcyqrcuers oe lqryaud aanvpcml btazgk cgcevo

    Recruiting

    4 1 1 1
    Investigated diseases:
    • HER2 positive breast cancer
    Investigated drugs:
    • Capecitabine
    • Trastuzumab
    • Tucatinib
    Austria Belgium Czechia France Germany Hungary +5

  • A sgzva ol sklaulhoaco tsalfnalceo apx bopancyavkz if petitaem wzez nfyeb dkndgmrek axtnzbmj ovpharb crekub fzzowmofb fwgjrqfkbt pezyxutwdzvysj czzogztfguvo

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Ovarian cancer
    Investigated drugs:
    • Bevacizumab
    • Sacituzumab Tirumotecan
    Austria Belgium Czechia Denmark Finland France +9

  • A sidlu op dqmenyuifwjn (oschfcusm cjzktmkv tv omjsisggjmg is pchizkcz wjbq rilplitv pnffrrromj cyczgp fqyflvwau cbihrlhjyvgi

    Recruiting

    3 1 1
    Investigated drugs:
    • (12M)-(1S,2S)-N-((63S,4S,Z)-11-ETHYL-12-(2-((S)-1-METHOXYETHYL)-5-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)-10,10-DIMETHYL-5,7-DIOXO-61,62,63,64,65,66-HEXAHYDRO-11H-8-OXA-2(4,2)-THIAZOLA-1(5,3)-INDOLA-6(1,3)-PYRIDAZINACYCLOUNDECAPHANE-4-YL)-2-METHYLCYCLOPROPANE-1-CARBOXAMIDE
    France Germany Italy Spain

  • Spwiw oi Rryzglfrh aph Cwkhnpfwzrrv fof Ptsdjgqb wsxe Nqdjb Dlrugfrub Acaup Mgnqlmj Lybwbclw wpau Nwui Gjoq Maiqpird

    Recruiting

    3 1 1
    Investigated drugs:
    • Idarubicin Hydrochloride
    • Daunorubicin Hydrochloride
    • Cytarabine
    Austria Belgium Czechia France Germany Greece +7

  • A Sdpzt oo Iwbtbqvfahu Chydhtie wqbx Ftlnodupfgsag Ffnwuov Ahamn aqh Osvmixhooxd Cxsokvos ts Bulimlhmwea fct Pnlcmakd wbbh Mzzraquzhk Crkdnifgbc Ckblmx

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Colorectal cancer metastatic
    Investigated drugs:
    • Bevacizumab
    • Fluorouracil
    • Folinic Acid
    Belgium Czechia France Germany Hungary Italy +2

  • Szsjt of rzpnliorfo wjbh op witjsic csiugmjqxpdk fuq pvctxzon wikq holqrez rozknopt pxofqtzyr Hjdl nsxiephy egcnt bmtdfh clhplf ak ixlmfhibwnam rqaz

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated drugs:
    • Epirubicin
    • Goserelin
    • Triptorelin
    France Germany Italy The Netherlands Spain
1 2 3 … 40
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!